Please assess the completion status of the following clinical trial:

Trial Title: MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Main selection criteria:~* Histologically proven stage Dukes  B2  (stage II: T3-T4 N0 M0) and  C  (stage III: any T N1-2 M0) colon carcinoma. The inferior pole of the tumor must be above the peritoneal reflection (\> 15 cm from the anal margin)·~* Complete resection of the primary tumor without gross or microscopic evidence of residual disease~* Treatment within 7 weeks following surgery~* Age 18-75 years old~* ECOG PS £ 2~* No prior chemo, immuno or radiotherapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).